Compare Vanguard Total International Stock Index Fund ETF (VXUS) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Total International Stock Index Fund ETF vs 22nd Century Group Inc — how do they compare? Vanguard Total International Stock Index Fund ETF trades at $84.95 (market cap $665.70B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Vanguard Total International Stock Index Fund ETF is far larger — about 1070825.4× 22nd Century Group Inc's market cap, and Vanguard Total International Stock Index Fund ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Total International Stock Index Fund ETF for 55 Days and 22nd Century Group Inc for 32 Days on average.
| VXUS | XXII | |
|---|---|---|
Market Cap | $665.70B | $621.67K |
Volume | 4,864,744 | 45,625 |
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $88.41 | $483.00 |
52-Week Low | $72.17 | $0.80 |
Typical Hold Time | 55 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VXUS trades at $84.82 with minimal daily movement (+0.05%), showing technical bearish signals across multiple indicators. The ETF faces selling pressure with moving averages and oscillators in bearish alignment, though RSI levels suggest potential oversold conditions. Recent news highlights VXUS as a core international diversification tool, with institutional investors increasing positions significantly during Q2 2026.
The outlook remains cautious due to technical weakness, but long-term prospects appear solid given VXUS's role in global portfolio diversification. Key risks include international market volatility and currency fluctuations, while institutional accumulation suggests confidence in international equity exposure despite near-term technical headwinds.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
